Functional Phosphoproteomics Finds Resolutions with Ion Mobility

Proteins are the molecular workhorses of life. In order for them to perform their physiological function, they need to be folded into unique 3D structures.

In the nearly two decades since the first successful use of gene therapy, transplantation of gene modified autologous hematopoietic stem cells (HSCs) is emerging as a viable treatment for a number of genetic blood cell and metabolic diseases and for some may even become standard of care.

Through genomic sequencing and analysis, clinicians can identify specific mutations present in a patient’s cancer cells and deliver personalized treatment based on the genetic information. Increased availability and lower costs of next-generation sequencing (NGS) and analysis, along with the on-going identification of an expanding array of cancer-related genetic mutations and biomarkers, are enabling exponential growth in the use of this diagnostic and therapy-targeting tool.

Take discovery and simple analysis to new heights. Learn about Thermo Fisher Scientific’s products’ BEA process monitoring capabilities – from simplifying tech transfer from research and process development into clinical trials and commercialization. This webinar aims to explain the benefits of working with the TruBio Discovery Automation System, as well as the Thermo ScientificTM Prima PRO Process Mass Spectrometer. The newest model of the Prima PRO Process Mass Spectrometer enhances results using a variable magnetic field to maximize ion separation within the scanning magnetic sector. Gain insights on how to maximize result accuracy alongside other systemic best practices.